Investigating the Anticancer Potential of Salvicine as a Modulator of Topoisomerase II and ROS Signaling Cascade.
DNA damage response (DDR)
ROS signaling
anticancer properties
diterpenoid quinone
multidrug-resistant (MDR)
topoisomerase II
Journal
Frontiers in oncology
ISSN: 2234-943X
Titre abrégé: Front Oncol
Pays: Switzerland
ID NLM: 101568867
Informations de publication
Date de publication:
2022
2022
Historique:
received:
18
03
2022
accepted:
02
05
2022
entrez:
20
6
2022
pubmed:
21
6
2022
medline:
21
6
2022
Statut:
epublish
Résumé
Salvicine is a new diterpenoid quinone substance from a natural source, specifically in a Chinese herb. It has powerful growth-controlling abilities against a broad range of human cancer cells in both
Identifiants
pubmed: 35719997
doi: 10.3389/fonc.2022.899009
pmc: PMC9198638
doi:
Types de publication
Journal Article
Review
Langues
eng
Pagination
899009Informations de copyright
Copyright © 2022 Dey, Hasan, Biswas, Papadakos, Rayan, Tasnim, Bilal, Islam, Arshe, Arshad, Farzana, Rahaman, Baral, Paul, Bibi, Rahman and Kim.
Déclaration de conflit d'intérêts
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Références
Int J Oncol. 1998 Mar;12(3):685-700
pubmed: 9472112
Nucleic Acids Res. 2013 Nov;41(20):9339-48
pubmed: 23945941
J Biol Chem. 2001 May 18;276(20):17420-8
pubmed: 11279018
Chem Biol. 2010 May 28;17(5):421-33
pubmed: 20534341
Mol Pharmacol. 2006 Nov;70(5):1593-601
pubmed: 16914642
Nature. 2012 Jan 18;481(7381):287-94
pubmed: 22258607
Eur J Cancer. 2020 Aug;135:251-259
pubmed: 32540204
Nat Rev Cancer. 2006 Oct;6(10):789-802
pubmed: 16990856
Blood. 1996 Apr 1;87(7):2649-58
pubmed: 8639880
Cancer Res. 2003 Aug 1;63(15):4527-32
pubmed: 12907627
Anticancer Res. 2000 Sep-Oct;20(5A):3117-21
pubmed: 11062731
Acta Pharmacol Sin. 2003 May;24(5):415-21
pubmed: 12740176
Blood. 2004 Dec 1;104(12):3746-53
pubmed: 15304390
J Med Chem. 2020 Feb 13;63(3):884-904
pubmed: 31592646
Eur J Cancer. 2010 May;46(7):1198-203
pubmed: 20303259
Free Radic Biol Med. 2008 Sep 1;45(5):627-35
pubmed: 18582559
Cancer. 1997 Oct 1;80(7):1250-7
pubmed: 9317175
Biochem Biophys Res Commun. 2004 Oct 15;323(2):660-7
pubmed: 15369801
Adv Pharm Bull. 2017 Sep;7(3):339-348
pubmed: 29071215
Mol Pharmacol. 2008 Mar;73(3):824-32
pubmed: 18025071
Biochim Biophys Acta. 2010 Feb;1804(2):245-62
pubmed: 19914407
Genes Dev. 1999 Jun 15;13(12):1553-60
pubmed: 10385624
Leukemia. 2002 Oct;16(10):2027-36
pubmed: 12357354
Bioorg Med Chem Lett. 1999 Sep 20;9(18):2731-6
pubmed: 10509925
Cancer Biol Ther. 2007 Nov;6(11):1794-9
pubmed: 18032928
Eur J Cancer. 2018 Dec;105:103-113
pubmed: 30445359
Int J Cancer. 2004 Jul 10;110(5):627-32
pubmed: 15146550
Cancer Lett. 2018 Aug 1;428:104-116
pubmed: 29704517
J Ethnopharmacol. 2021 Dec 5;281:114577
pubmed: 34464698
Mol Pharmacol. 2005 Oct;68(4):983-94
pubmed: 16024664
Cancer Lett. 2013 Jun 28;334(1):86-94
pubmed: 23111102
Glycobiology. 2018 Sep 1;28(9):648-655
pubmed: 29272415
Oxid Med Cell Longev. 2016;2016:4350965
pubmed: 26998193
Clin Cancer Res. 2005 May 1;11(9):3455-64
pubmed: 15867248
Science. 2000 Jan 7;287(5450):131-4
pubmed: 10615047
J Signal Transduct. 2011;2011:792639
pubmed: 21637379
J Biol Chem. 2015 Apr 10;290(15):9348-61
pubmed: 25697362
Eur J Nutr. 2021 Apr;60(3):1561-1586
pubmed: 32770356
Redox Biol. 2019 Jul;25:101084
pubmed: 30612957
Biochim Biophys Acta. 2012 Sep;1822(9):1363-73
pubmed: 22178243
Toxicol Pathol. 2007 Jun;35(4):495-516
pubmed: 17562483
Nat Rev Mol Cell Biol. 2002 Jun;3(6):430-40
pubmed: 12042765
Molecules. 2021 Nov 11;26(22):
pubmed: 34833913
J Immunol. 2007 Jan 1;178(1):103-10
pubmed: 17182545
Cancer Res. 2006 Jun 1;66(11):5807-15
pubmed: 16740720
Cell. 2007 Oct 19;131(2):223-5
pubmed: 17956720
Mol Oncol. 2015 Mar;9(3):601-16
pubmed: 25435281
Front Oncol. 2021 Feb 01;10:633142
pubmed: 33598437
Phytother Res. 2006 Aug;20(8):701-3
pubmed: 16676297
Prev Med. 2021 Oct;151:106585
pubmed: 34217412
Blood. 2009 Aug 27;114(9):1813-9
pubmed: 19571320
Int Immunopharmacol. 2014 Aug;21(2):447-55
pubmed: 24905636
Zhongguo Yao Li Xue Bao. 1999 Apr;20(4):297-302
pubmed: 10452112
Genes Dev. 2011 Mar 1;25(5):409-33
pubmed: 21363960
Clin Exp Metastasis. 2005;22(2):99-106
pubmed: 16086230
Blood. 2002 Jun 1;99(11):3885-91
pubmed: 12010785
Biochem J. 1996 Jan 1;313 ( Pt 1):17-29
pubmed: 8546679
Nat Rev Cancer. 2012 Dec;12(12):801-17
pubmed: 23175119
J Biol Chem. 2003 May 30;278(22):20303-12
pubmed: 12660252
Cells. 2020 Jan 13;9(1):
pubmed: 31941155
Acta Pharmacol Sin. 2007 Sep;28(9):1460-5
pubmed: 17723179
J Biol Chem. 1994 Jan 14;269(2):1173-6
pubmed: 8288578
Oral Oncol. 2000 Mar;36(2):236-41
pubmed: 10745178
Acta Pharm Sin B. 2015 Sep;5(5):402-18
pubmed: 26579471
Semin Cancer Biol. 2002 Apr;12(2):89-96
pubmed: 12027580
Adv Drug Deliv Rev. 2002 Nov 18;54(10):1295-310
pubmed: 12406646
Lung Cancer. 2018 Apr;118:69-75
pubmed: 29572006
Curr Biol. 2002 Mar 5;12(5):397-402
pubmed: 11882291
J Biol Chem. 2003 Sep 19;278(38):35897-902
pubmed: 12842886
Nucleic Acids Res. 2009 May;37(8):2539-48
pubmed: 19264794
Cancer. 2007 Mar 1;109(5):891-8
pubmed: 17265529
Blood. 2007 Feb 15;109(4):1643-52
pubmed: 17047150
Cancer Chemother Pharmacol. 2005 Mar;55(3):286-94
pubmed: 15592835
Biochem Pharmacol. 2002 Dec 15;64(12):1677-87
pubmed: 12445857
Oncol Rep. 2009 Jun;21(6):1593-7
pubmed: 19424641
CA Cancer J Clin. 2021 Jan;71(1):7-33
pubmed: 33433946
Zhonghua Zhong Liu Za Zhi. 2013 Sep;35(9):655-9
pubmed: 24332051
Br J Haematol. 2006 Sep;134(5):500-9
pubmed: 16869825
Biochemistry. 2001 Mar 20;40(11):3316-23
pubmed: 11258951
FEBS Lett. 2001 Jul 13;501(1):59-64
pubmed: 11457456
Immunol Rev. 2003 Aug;194:77-95
pubmed: 12846809
Nat Rev Mol Cell Biol. 2008 Apr;9(4):297-308
pubmed: 18285803
Science. 2017 Nov 10;358(6364):797-802
pubmed: 29123070
Cancer Res. 1999 Jan 15;59(2):391-8
pubmed: 9927052
Nat Rev Cancer. 2002 Feb;2(2):91-100
pubmed: 12635172
Nature. 1954 Oct 9;174(4432):689-91
pubmed: 13213980
Genes (Basel). 2019 Oct 30;10(11):
pubmed: 31671531
Cancer Discov. 2018 May;8(5):537-555
pubmed: 29653955
Nucleic Acids Res. 2013 Dec;41(22):10630-40
pubmed: 24038465
Cancer Res. 2005 May 15;65(10):4020-30
pubmed: 15899791
Leukemia. 1998 Jun;12(6):887-92
pubmed: 9639416
Biochem Soc Symp. 2006;(73):181-9
pubmed: 16626298
PLoS One. 2013 Nov 19;8(11):e81162
pubmed: 24260552
Sci Transl Med. 2014 Feb 5;6(222):222ra18
pubmed: 24500406
Int J Cell Biol. 2012;2012:676731
pubmed: 22505933
EMBO J. 1996 Oct 15;15(20):5616-26
pubmed: 8896455
Cancer Res. 2001 Aug 1;61(15):5926-32
pubmed: 11479235
Molecules. 2022 Jan 13;27(2):
pubmed: 35056809
Antioxid Redox Signal. 2014 Jun 10;20(17):2873-89
pubmed: 24156355
Proc Natl Acad Sci U S A. 2017 Jun 13;114(24):E4782-E4791
pubmed: 28533414
Front Pharmacol. 2016 Dec 02;7:465
pubmed: 27994550
J Biomed Res. 2021 Nov 6;35(6):459-473
pubmed: 34857680
Biochem Pharmacol. 2001 Sep 15;62(6):733-41
pubmed: 11551518
Faraday Discuss. 2004;126:103-17; discussion 169-83
pubmed: 14992402
Front Oncol. 2020 Mar 05;10:265
pubmed: 32195185
Cell Cycle. 2007 Feb 15;6(4):414-7
pubmed: 17312392
Blood. 2010 Dec 9;116(24):5298-305
pubmed: 20807885
Science. 2008 Mar 7;319(5868):1352-5
pubmed: 18323444
Biochem Pharmacol. 2011 Dec 15;82(12):1843-52
pubmed: 21924246
Mod Pathol. 2000 May;13(5):542-7
pubmed: 10824926
Curr Opin Hematol. 1999 Jul;6(4):241-6
pubmed: 10400373
Cancer Lett. 2008 Oct 18;270(1):1-9
pubmed: 18467025
Biomedicines. 2020 Nov 19;8(11):
pubmed: 33228222
Biochim Biophys Acta Rev Cancer. 2018 Apr;1869(2):321-332
pubmed: 29673969
J Pers Med. 2021 Sep 06;11(9):
pubmed: 34575665
Oral Oncol. 2004 May;40(5):461-73
pubmed: 15006617
Anticancer Drugs. 2001 Jan;12(1):51-6
pubmed: 11272286
Bioorg Chem. 2021 Feb;107:104395
pubmed: 33384144
Evid Based Complement Alternat Med. 2021 Aug 30;2021:8922196
pubmed: 34504541
J Cell Biochem. 2013 Mar;114(3):532-40
pubmed: 22961925
Pharm Biol. 2013 Aug;51(8):1061-5
pubmed: 23750780
Int J Cancer. 2003 Aug 10;106(1):108-15
pubmed: 12794765
Int J Mol Sci. 2018 Nov 09;19(11):
pubmed: 30423952
Cancers (Basel). 2021 Sep 25;13(19):
pubmed: 34638282
J Ethnopharmacol. 2022 Mar 1;285:114900
pubmed: 34896569
Cancer Commun (Lond). 2019 Apr 29;39(1):22
pubmed: 31030667
Zhonghua Zhong Liu Za Zhi. 2005 Dec;27(12):721-6
pubmed: 16483481
Mutat Res. 2011 Jun 3;711(1-2):167-73
pubmed: 21419141
Annu Rev Med. 2015;66:129-43
pubmed: 25423595
Sci Rep. 2018 Sep 17;8(1):13902
pubmed: 30224635
J Hum Genet. 2021 Mar;66(3):307-314
pubmed: 33046835
Cancers (Basel). 2014 Sep 05;6(3):1769-92
pubmed: 25198391
J Biol Chem. 2014 Jul 18;289(29):19881-93
pubmed: 24891506
J Immunol Methods. 1999 Dec 17;232(1-2):3-14
pubmed: 10618505
Mol Cancer Res. 2008 Feb;6(2):194-204
pubmed: 18314480
Ann N Y Acad Sci. 2014 Mar;1310:98-110
pubmed: 24495080
Mutat Res. 2007 Oct 1;623(1-2):83-97
pubmed: 17681352
Sci Rep. 2018 Jan 17;8(1):967
pubmed: 29343829
Free Radic Biol Med. 2019 Jan;130:436-445
pubmed: 30395972
Trends Pharmacol Sci. 2006 Jun;27(6):338-44
pubmed: 16697054
Front Pharmacol. 2020 Jan 28;10:1614
pubmed: 32116665
Mol Cell. 2004 Dec 3;16(5):715-24
pubmed: 15574327
Nucleic Acids Res. 2018 Jan 4;46(D1):D1074-D1082
pubmed: 29126136
Nat Cell Biol. 2014 Jan;16(1):2-9
pubmed: 24366029
Biochem Pharmacol. 2018 Oct;156:479-490
pubmed: 30222967
Cell. 2006 Nov 17;127(4):679-95
pubmed: 17110329
Environ Sci Pollut Res Int. 2021 Nov;28(42):59570-59593
pubmed: 34510341
FASEB J. 2003 Jul;17(10):1195-214
pubmed: 12832285
Toxicology. 2004 Jul 15;200(1):59-68
pubmed: 15158564
Anticancer Res. 2001 Jul-Aug;21(4A):2585-9
pubmed: 11724325